- Bulls Stadium, California
- 666-888-0000
- info@example.com
06May
How non-scientific it is to take Vitamin D supplements by Indians?
India is a vast tropical country extending from 8.4º N latitude to 37.6° N latitude, with majority of its population living in areas receiving ample sunlight throughout the year. Enough […]
29Mar
Orphan Drug Pricing and Reimbursement -Part II
The growing cost of discovery and development of orphan drugs is having an overall impact on the patient access to orphan medicines. Orphan drugs, which are usually not covered by […]
15Mar
How rational is banning irrational drug combinations in India?
Fixed Dose Combinations (FDCs) refers to the combination of drugs that includes two or more active pharmaceutical ingredient combined in a single dosage form which is manufactured and distributed in […]
29Feb
Orphan Drug Pricing and Reimbursement – Part I
On the eve of “World Rare Disease Day” today, February 29, 2016 (the rarest day of the year), I planned to post a two series blog post on “Orphan Drug […]
11Feb
What Makes Medical Devices Costly?
Medical devices may well sound like a modern invention but they have helped us control and treat diseases for centuries. Medical gadgets play a considerable role in our lives, many […]
07Feb
Biosimilar: Does It Burn Your Pocket?
The high cost of pharmaceuticals, especially biologics, has become an important issue in the battle to control healthcare costs. In order to overcome this impediment, biosimilar unlike generics were first […]
02Feb
“Voice of the Patient” in Improving Drug Access
Drugs which might seem very effective in clinical trials, sometimes fail in the market due to non compliance and acceptability issues from the patients. On the other hand, a drug […]
18Jan
How Can We Cap Skyrocketing Pharmaceutical Prices: The Even Bigger Question?
To most connected with the pharmaceutical industry, it is a common knowledge that the cost of prescription medicine, even traditionally, has always defied the law of gravity. However; what is […]